Drug Companies Fight Over Weight Loss Pills

Novo Nordisk and Eli Lilly are competing to develop oral versions of their weight loss drugs, following the success of their injectable products. The companies are preparing to launch these pills in many countries after initial success in the United States. This reflects growing demand for obesity treatments globally.

Summarized from the sources above. Read the originals for the full story.